Login / Signup

Current Status and Future Opportunities in Lung Precision Medicine Research with a Focus on Biomarkers. An American Thoracic Society/National Heart, Lung, and Blood Institute Research Statement.

Ann Chen WuJames P KileyPatricia J NoelShashi AmurEsteban González BurchardJohn P ClancyJoshua M GalanterMaki InadaTiffanie K JonesJonathan A KropskiJames E LoydLawrence M NogeeBenjamin A RabyAngela J RogersDavid A SchwartzDon D SinAvrum E SpiraScott T WeissLisa R YoungBlanca E Himes
Published in: American journal of respiratory and critical care medicine (2019)
Although progress has been made toward implementation of precision medicine for lung diseases in clinical practice in certain settings, additional studies focused on addressing specific unmet clinical needs are required to evaluate the clinical utility of biomarkers; ensure their generalizability to diverse, real-life populations; and determine their cost-effectiveness.
Keyphrases
  • clinical practice
  • quality improvement
  • healthcare
  • heart failure
  • primary care
  • atrial fibrillation
  • genetic diversity